Tryptophanase, encoded by the gene tnaA, is a catabolic enzyme distinct from the enzymes of tryptophan biosynthesis. Tryptophanase synthesis is induced by tryptophan and is subject to catabolite repression. We studied the mechanism of tna operon induction. Mutants with altered p factor were partially constitutive for tna expression, implicating p-dependent transcription termination in the control of tna expression. Measurements of mRNA synthesis from the transcribed leader region preceeding the tna operon suggested that the tna promoter was constitutive and that in the absence of inducer, transcription terminated in the leader region. Upon induction, this transcription termination was relieved. Cis-acting constitutive mutants had genetic alterations in the tna leader region. These lesions defined a site that is homologous to the bacteriophage A boxA sequence, which is thought to play a role in antitermination control of k lytic gene expression. We propose that tna expression is subject to transcription antitermination control. We hypothesize that a tryptophan-activated antiterminator protein mediates induction by suppressing the p-dependent termination sites in the leader region, thus allowing transcription to proceed into the tna operon structural gene region.
Tryptophanase is a multifunctional enzyme found exclusively in bacteria. The structure, enzymatic activities, and reaction mechanisms of Escherichia coli tryptophanase are well understood (34, and references therein). One tryptophanase reaction, a p-elimination, involves degradation of tryptophan to form indole, pyruvate, and ammonia.
Other p-elimination substrates include cysteine, Smethylcysteine, and serine (44) . Tryptophanase also catalyzes replacement reactions, including the condensation of cysteine or serine with indole to form tryptophan (44) . The elimination reaction itself is reversible: under appropriate conditions, tryptophanase can synthesize tryptophan from indole, pyruvate, and ammonia (61) .
The tna operon contains at least two genes. The promoterproximal gene, tnaA, encodes tryptophanase (17) . The second gene, tnaB, is required for low-affinity tryptophan permease activity (13, 17, 20 ; V. Stewart and C. Yanofsky, unpublished observations). Expression of the E. coli tna operon is induced by tryptophan and is subject to catabolite repression (see below). Thus, tryptophanase probably serves a catabolic role in vivo. In the laboratory, E. coli will grow with tryptophan as the sole source of carbon and energy (46) . Some of the major effects of catabolite repression are believed to be mediated through cyclic AMP (cAMP) plus the cAMP receptor protein (cAMP-CRP). The cAMP-CRP complex makes up a positive-acting element required for efficient transcription initiation at catabolite-sensitive promoters; mutants deficient in CRP or adenylate cyclase are incapable of inducing the tna operon (reviewed in reference 16). However, other factors, independent of cAMP, probably also play significant roles in the catabolite repression of tna operon expression (10, 11) .
Newton and Snell (43, 45) use tryptophanase to synthesize tryptophan from indole plus cysteine, and second, that 5-methyltryptophan (5MT) is an efficient inducer of tryptophanase synthesis. Thus, a mutant lacking tryptophan synthetase (encoded by genes trpB and trpA) will grow on a tryptophan-free medium that contains both indole and 5MT. Newton and Snell extended this selection to isolate a regulatory (constitutive) mutant by selecting for growth on indole medium lacking 5MT.
This selection for constitutive mutants has been used in other laboratories (18, 21, 26) . However, few of these mutants have been characterized in detail. No trans-acting regulatory alterations have been described, and the genetic basis of tna regulation has remained unknown. Others have found that the kinetics of tna induction are very similar to those for lac, but these observations have not been pursued (7) .
The tna operon has been cloned and sequenced (17; V. Stewart and C. Yanofsky, unpublished observations). In vitro transcription experiments located a cAMP-CRPdependent promoter 319 base pairs proximal to the tnaA initiation codon (18) . It has been postulated that this is the tna promoter and that the intervening transcribed leader region is involved in regulating tna expression (18) .
We report here an analysis of tna regulation. We found that strains with altered p factor were partially constitutive for tna expression. Measurements of mRNA synthesis provided evidence for regulated transcription termination in the leader region preceeding the tnaA gene. Constitutive mutants harbored single-base-pair changes in the tna leader region. These alterations were cis-acting and were located in a short coding region, which we designate tnaC. The region defined by most of these tnaC lesions is homologous to a sequence boxA, that is important for antitermination control of bacteriophage X gene expression (23, 24, 48, 49) . We propose a model for transcription antitermination control of tna operon expression that is analogous to that for X lytic gene expression. We hypothesize that a tryptophanresponsive antitermination protein mediates tna operon in- SVS102  SVS113  SVS120  SVS121  SVS124  SVS300   SvS1100   SVS1142   SVS1144   SVS1500   SVS1600   SVS1650   SVS1651   SVS1652   SVS1653   SVS1654   SVS1655   SVS1656   SVS1657   SVS1658   SVS1659   SVS1660   SVS1661   SVS1744   SVS1746   SVS1844   SVS1846 F-A-prototroph hsdR514 supE44 supF58 lacY) galK2 gal722 metBi trpRSS supD43,74 sueA sueC leu(Am) lac(Am) galK(Am) galE rpsL metB relA As LE392 but A(trpEA)2 tnaA2b bglR551 recA56 As LE392 but A(lac-argF)U169 recA56 As MX397 but A(trpEA)2 rho-15 rho-101 rho-102 rho-103 bglR551 bgIR551 tnaA2b bglR551 bgl-552::TnJO bglR551 trpR2 bglR551 trpS10343 bglRS51 nusAl bglR551 A(trpEA)2 duction by suppressing transcription termination in the leader region.
MATERIALS AND METHODS
Strains. The E. coli K-12 strains employed in this study are listed in Table 1 . All strains except SVS1 through SVS4 were derived from the prototroph W3110. For simplicity, only the final strains are listed. Genetic crosses were performed by bacteriophage P1 kc-mediated generalized transduction (40) . In most cases, strains were constructed with the aid of transposon insertions (15, 36) . For example, recA alterations were introduced by a two-step procedure: first, the strain was transduced to srl-300::TnJO; and second, the srl derivative was transduced to srl+ recA.
The tryptophanase (tna) operon is closely linked to cryptic genes (termed bg() for utilization of 3-glucosides such as salicin (3) . A spontaneous Bgl+ (bglR551) strain was isolated as a red papillus from a colony of W3110 growing on MacConkey-salicin medium (53) to provide a convenient selectable marker for introducing tna alleles into Bglstrains.
rho alleles were cotransduced with ilv+ into strain W3110 lacZU118 ilv::TnJO. Ilv+ transductants were screened for suppression of the LacY-phenotype by the donor rho lesion (37) . The allele rho-15 is generally considered to confer a temperature-sensitive phenotype (31) . However, strain SVS7 (rho-15) was not temperature sensitive, in agreement with the findings of others (5, 32) .
Media. Media for routine use, including LB, X, and supplemented minimal media, were prepared from standard recipies (15) . E minimal medium was used for preparing defined agar media (57) . Medium for selecting tna+ was E medium supplemented with 0.2% potassium succinate, 0.2% acid-hydrolyzed casein (AHC), 10 ,ug of indole per ml, 50 ,ug of 5MT per ml, and 20 ,ug of cysteine per ml. This formula is adapted from that of Newton and Snell (45) . 5MT is poorly incorporated into protein and thus is nontoxic under these conditions (19) . Medium ,-Galactosidase activities were determined by measuring the hydrolysis of o-nitrophenyl-p-D-galactoside to onitrophenol. The assay procedure closely followed the one described by Miller (40) . A sample of cell extract in Z buffer (40) was mixed with Z buffer to a final volume of 1 ml. The assay was started by adding 0.2 ml of 4-mg/ml o-nitrophenyl-,-D-galactoside in Z buffer and stopped by adding 0.5 ml of 1 M Na2CO3. The optical density was measured at 420 nm, and activity was calculated by assuming an extinction coefficient for o-nitrophenol of 4,500 M-1 cm-' (40).
Mutant isolation. Tryptophanase constitutive mutants (TnaC-) were isolated from strains SVS4 and SVS300. Ethyl methanesulfonate and 2-aminopurine mutageneses were performed exactly as described by Miller (40) . Samples of cultures were plated on the indole-selective medium (lacking 5MT) described above. After 2 days of incubation at 42°C (SVS4) or 370C (SVS300), colonies were picked and purified by single-colony isolation on selective medium. Each allele described in this paper represents an independent mutational event, because only a single isolate from each culture was retained for analysis. Genetic alterations were mapped by generalized transduction with SVS113 (bgl-552::TnJO) as the donor. Alleles analyzed in this study were cotransduced into strain SVS300 by linkage to bgl-552::TnJO. These strains were then crossed back to Bgl+ by transduction from SVS300.
Strain MX397 contains a temperature-sensitive allele of supD, so that strains carrying amber lesions have the mutant phenotype at 42°C but show the wild-type (i.e., suppressed) phenotype at 30°C (47) . A derivative of MX397, SVS4, allowed the selection of TnaC-mutants. More than 500 mutants were selected at 42°C, but none appeared to be wild type at 30°C.
Replica plating was used to screen pools of random chromosomal TnJO or TnS transposon insertions for TnaCor Bgl-mutants (15, 36, 62) . No TnaC-mutants were recovered after mutagenesis with TnS (approximately 100,000 colonies screened) or TnJO (over 60,000 colonies screened).
Molecular cloning. Standard methods were used for routine cloning, including restriction endonuclease digestion, ligation, transformation, gel electrophoresis, etc. (15) . DNAmodifying enzymes were either purchased from commercial suppliers or purified in our laboratory by published procedures. Plasmid DNA was isolated by the alkaline lysis procedure (8) . Large-scale plasmid preparations were purified by CsCl-ethidium bromide equilibrium density gradient ultracentrifugation (15) . tnaC alleles were cloned by recombination in vivo, following the method of Stauffer et al. (56) . Plasmid pMD4 carries DNA from the tna region ofE. coli, except that it contains an internal deletion removing the tna promoter, leader, and N-terminal coding sequence of tnaA (17) . pMD4 was transformed into tnaC strains, and transformants were clutured for several generations to allow the chromosomal tna region to recombine onto pMD4. Isolated plasmid DNA was used to transform strain SVS1, and the cells were plated on indole-SMT-tetracycline medium. Tna+ transformants contained recombinant plasmids carrying the intact tna region from the donor strain, including the donor tnaC lesion.
Gene fusions. Published methods were used to construct gene fusions (35, 64) (Fig. 1) . Plasmid pRLK15, a derivative of pMC931, contains an engineered lacZ gene that replaces the coding region for the first seven amino acid residues with a Ba,nHI restriction site (14, 64) . Fragment AluI-RsaI619 from the pMD4-recombinant plasmids (described above) and fragment RsaI910 from the tnaA+ plasmid pMD6 (17) coding region for tnaA (Fig. 2) . The distal RsaI site occurs at tnaA codon 21 (17) . BamHI molecular linkers (5'-CCGGATCCGG-3'; Bethesda Research Laboratories, Inc., Gaithersburg, Md.) were ligated to the ends of the fragments; the DNA sequence is such that cloning these BamHI fragments into pRLK15 produced in-phase tnaA'-lacZ+ gene fusions. Fragment AluI-Sau3AI325 was used to construct the tnaC'-lacZ+ hybrid gene fusion (17) . In this case, the Sau3AI site within the tnaC coding region overlapped the BamHI site in pRLK15 to directly produce an in-phase gene fusion (Fig. 2) . Recombinant plasmids from several transformants were analyzed to identify those with the proper tna'-lacZ+ gene fusions.
Rec+ strains carrying selected plasmids were used as hosts to prepare lysates of bacteriophage XRL1, which shares homology with the regions flanking the lacZY sequence in pRLK15. Thus, the resulting phage lysates contained recombinant phage which had acquired the tna'-lacZ+ fusions from the plasmid (35) . Strain SVS1100 was transduced with fusion-bearing specialized transducing phages isolated from these lysates (15) . All gene fusion experiments reported in this paper were done with singlecopy lysogens (4) .
DNA sequencing. The chemical cleavage procedure of Maxam and Gilbert was used for all DNA sequence analyses (39) . The reaction products were resolved on thin 8 or 20% acrylamide-7 M urea gels (55) or on 6% acrylamide-7 M urea buffer gradient gels (6) . mRNA levels. Cultures (10 ml) growing in MOPS-AHC medium were pulsed with [3H]uridine for 30 s, and RNA was isolated by previously described methods (65) . The RNA was hybridized to 2 ,ug of plasmid DNA that had been immobilized on nitrocellulose filters (BA85; Schleicher & Schuell, Inc., Keene, N.H.). Conditions for hybridization and quantitation procedures have been described previously (64) .
tnaA mRNA was measured by hybridization to HindIIIdigested pMD6 plasmid DNA, less background hybridization to the vector, pBR322. lacZ mRNA was measured by hybridization to BamHI-digested pMC931'DNA, less background hybridization to the vector, pACYC177. The data reported in the text are the averages of two independent experiments. RESULTS Culture conditions. We measured tryptophanase production in cultures after growth in MOPS medium supplemented with AHC as a source of carbon and energy (9, 42) . Strain W3110 grew with a doubling time of approximately 70 to 75 min in this medium, and its growth was exponential to a density of greater than 5 x 108 CFU/ml (over 100 Klett units). Tryptophanase specific activity increased with the level of tryptophan in the medium up to 0.5 mM. Specific activity was further increased only slightly by tryptophan concentrations as high as 20 mM, so we usually added 0.5 mM tryptophan for induction.
In several studies it has been shown that catabolite repression has a more severe effect on tryptophanase formation than on ,B-galactosidase formation (10, 11; and references therein). We observed similar effects in MOPS-AHC medium supplemented with both 20 mM tryptophan and 20 mM of any of several carbon sources (data not shown). Glucose, lactose, and arabinose each repressed tryptophanase synthesis to less than 1% of the control value. Even relatively poor carbon sources, such as glycerol or pyruvate, resulted in catabolite repression of tryptophanase synthesis to about 5 to 10% of the control value. In contrast, glycerol or pyruvate had little effect on P-galactosidase synthesis.
Tryptophanase production in various mutants. Strains carrying lesions in trpR or trpS showed essentially wild-type tryptophanase levels with or without induction ( Table 2) . We believe that the slightly elevated uninduced tryptophanase level in the trpR strain simply reflected overproduction of tryptophan in this mutant. These findings suggest that tna regulation is distinct from that of the trp operon.
Other studies (see below) indicated that p-dependent transcription termination may be involved in tna regulation. Indeed, several rho mutants were partially constitutive for tryptophanase production ( Table 2 ). The nusAl allele reduces N gene product-mediated antitermination coptrol in bacteriophage A (24), but it had little effect on tna expression (Table 2) .
Comparision of tna induction by tryptophan and 5-MT. Newton and Snell (45) showed that 5MT is an efficient tryptophanase inducer. We extended their results, using a tnaA'-IacZ+ gene fusion to monitor the induced rate of tryptophanase production. We grew parallel cultures of strain SVS1S00 in MOPS-AHC medium supplemented with 0.05 mM tryptophan. At cell densities of about 3 x 108 CFU/ml, we added L-tryptophan to a final conentration of 0.5 mM or 5-methyl-DL-tryptophan to a final concentration of 1 mM. We removed samples at 5-min intervals and assayed P-galactosidase activity directly in permeabilized cells (40) . The rate of hybrid ,3-galactosidase synthesis was similar with either tryptophan or 5MT as inducer, approximately 40 U of activity per min per 108 CFU.
Comparison of tnaA and tnaC expression. The tna leader region (tnaL) contains a coding sequence (tnaC) for a 24-residue peptide (Fig. 2) . Strains carrying a tnaC'-IacZ+ gene fusion produced active P-galactosidase, indicating that this coding region was translated in vivo (see below). Thus, the transcript of tnaL contains a translated region, tnaC, and a long untranslated region, from +100 to +319 (Fig. 2) .
The tnaC'-locZ+ fusion deleted the nontranslated portion of the leader region (Fig. 1) . Comparing the relative expression of tnaC'-lacZ+ and tnaA'-lacZ+ suggested a regulatory role for this region. P-Galactosidase synthesis from tnaC'- (18) . The consensus promoter sequence is shown directly below the -10 and -30 regions (33) . The cAMP-CRP binding site is at -60; the consensus sequence is shown directly below (16) . Shine-Dalgarno regions are marked with asterisks (28). The Sau3AI site at +85 was used to construct the tnaC'-IacZ+ gene fusion (Fig. 1) . The sequence shown differs from that previously reported (17) at three positions: an additional A at +138; A instead of T at +150; and C instead of T at +358. lacZ' was insensitive to the presence of tryptophan and was repressed about 10-fold by glucose (Table 3) . This indicates that transcription initiation from the tna promoter is subject to catabolite repression but not to tryptophan control. In contrast, 0-galactosidase synthesis from tnaA'-lacZ+ was induced about 20-fold by tryptophan; the induced level was repressed over 100-fold by glucose (Table 3) .
We pulse-labeled the same cultures with [3H]uridine and measured the rate of specific mRNA synthesis. In the absence of tryptophan, lacZ mRNA production from tnaC'-lacZ was high, whereas that from tnaA'-IacZ+ was low (Table 3 ). In the presence of tryptophan, lacZ mRNA production from both funsions was high. This suggests that the region between tnaC and tnaA contains a tryptophanresponsive transcription terminator and that this terminator is used to regulate tna expression.
We also measured tryptophanase enzyme activity and tnaA mRNA levels in the same experiments. The relative levels of tnaA induction paralleled those of tnaA'-lacZ+ (Table 3 ), suggesting that the tnaA'-lacZ+ gene fusion provided a legitimate indicator of tnaA expression.
Under inducing conditions, the hybrid P-galactosidase specific activity from tnaC'-lacZ+ was 20-fold lower than that from tnaA'-lacZ+, even though tnaC'-lacZ+ produced nearly twice as much lacZ mRNA (Table 3) . This difference may have been due at least in part to a lower rate of translation initiation at tnaC, although the specific activities or stabilities of the two hybrid enzymes may also have differed. The spacing between the Shine-Dalgarno region and the AUG initiation codon of tnaC is 10 base pairs (Fig.  2) , which may result in relatively poor translation of the tnaC coding region (28) .
The induction ratios of the tnaA'-IacZ+ enzyme and of tryptophanase were approximately 20 and 100, respectively. An analogous observation was made in comparing trpE and trp-lac expression (64) . Others have noted that the induced rate of tryptophanase synthesis is lower when the tnaA gene is located at A att, on a specialized transducing prophage (59 We chose 12 mutants for detailed analysis and backcrossed each to strain SVS300. Six of the alleles were isolated in Strain SVS4 (naC250 to tnaC255), and six were isolated in strain SVS300 (tnaC256 to tnaC261). These mutants represented the range of phenotypes we observed, from relatively poor to excellent growth on indole medium lacking 5MT. We mapped three alleles by reciprocal threepoint crosses and found the order tnaC-tnaA2-bgIR (data not shown). a The induced specific activity in SVS1600 is set at 100%. Expression and complementation analysis. The tnaC mutants were partially constitutive, expressing tnaA at uninduced levels approximately 20 to 80% of the wild-type induced level. Most responded to inducer, and many were hyperinducible, with induced levels approximately 150 to 180% of the wild-type induced level (Table 4) . We also examined glycerol-and glucose-mediated catabolite repression in these mutants, but none showed more than a slight relief of catabolite repression on either carbon source (data not shown). Thus, the phenotypes of these strains were very similar to those of previously reported constitutive mutants, termed tnaR (18, 21, 26) .
All tna constitutive mutants previously tested are cisdominant (18, 21, 27) . We used a tnaA'-lacZ+ gene fusion for complementation tests, to determine the cis-trans beha'vior of our tnaC mutants. We constructed trp+ Alac recA derivatives of each of the 12 tnaC mutants, lysogenized each derivative with a tnaA'-lacZ+ specialized transducing phage, and measured both tryptophanase and ,B-galactosidase specific activities after growth under noninducing or inducing conditions. Each mutant exhibited constitutive tryptophanase production but retained wild-type-like regulation of the hybrid 3-galactosidase product (Table 4) . Thus, the tnaC lesions were cis-dominant, as defined by this test.
We constructed a maA'-lacZ+ gene fusion carrying the tnaC2SS allele to confirm the validity of MaA'-lacZ+ as an indicator for the complementation analyses described above. We measured both tryptophanase and ,I-galactosidase specific activities in a set of four strains (SVS1744, 1746, 1844, 1846) carrying all possible combinations of tnaC+ or tnaC255 linked to either tnaA+ or tnaA'-lacZ+. The tnaC255 allele conferred a strictly cis-acting phenotype, regardless of its chromosotnal location (data not shown).
DNA sequence analysis. The above experiment demonstrated that the tnaC255 lesion was contained within the AluI-RsaI619 restriction fragment. This fragment contains the tna promoter and leader region, as well as the first 20 codons of tnaA. We determined the DNA sequence, on both strands, for both the wild-type and the tnaC255 AluIRsaI619 fragments. The DNA sequences differed at a single position, withn MaC. We Nucleotide sequence changes in tnaC alleles. Only the relevant portion of the wild-type leader region nucleotide sequence around position +99 is shown (Fig. 2) . A consensus boxA sequence is shown directly below the tnaC sequence at positions 90 to 99 (24) . The nucleotide change resulting from each mutational event is shown below the sequence. Mutagens: EMS, ethyl methanesulfonate; 2AP, 2-aminopurine. region in each of the recombinant pMD4 plasmids which carried the remaining tnaC alleles. In each mutant, we found a single base change in tnaC (Fig. 3) . The 12 independent mutants defined six different changes from the wild-type sequence. Some of these changes were represented by only a single example, so other tnaC lesions may exist.
Attempt to mimic the TnaC-phenotype. One class of tnaC lesion changed the tnaC opal termination codon (UGA) to a tryptophan codon (UGG). This alteration would allow translation to proceed to the amber codon (UGA) located five codons downstream from the tnaC opal termination codon (Fig. 3) . We attempted to examine the contribution of this additional translation to the TnaC-phenotype by introducing an efficient opal suppressor, Su7-UGA, into an otherwise wild-type strain. Su7-UGA probably inserts tryptophan and is expressed from a lac promoter in plasmid pSWC101 (51) . The level of tryptophanase was indistinguishable between strains with plasmids carrying either Su°(strain SVS1910) or Su7-UGA (SVS1911) and was indifferent to the lac inducer, isopropyl-p-D-thiogalactoside (data not shown). Control experiments established that SVS1911 expressed the opal suppressor. This result suggests that translational readthrough was not responsible for the constitutive phenotype in this class of tnaC mutant, although it is also possible that the Su7-UGA suppressor is inefficient in this particular context.
DISCUSSION
The evidence presented in this paper has led us to draw several conclusions regarding tna operon expression. We will consider each in turn and then propose a working hypothesis for tna regulation based on these conclusions. tna operon regulation is distinct from tip operon regulation.
The tryptophan (trp) biosynthetic operon is regulated by two mechanisms: tryptophan-mediated repression and tryptophanyl-tRNATrP-mediated attenuation (64) . The tryptophan aporepressor lesion trpR2 had no significant effect on tryptophanase induction (Table 2 ). We conclude that the trpR product plays no direct role in tna expression.
Attenuation in the trp operon responds to the level of tryptophanyl-tRNATrP and is relieved in certain mutants altered in trpS, the structural gene for tryptophanyl-tRNATp synthetase (19, 63) . The trpS10343 lesion had no effect on tna expression (Table 2) . Further, tryptophanase synthesis was efficiently induced by 5MT (45; this work), which is very poorly charged onto tRNATIP (19) . Thus, we conclude that tna expression is not influenced by the level of tryptophanyltRNATIp. This is consistent with the in vivo role of an amino-acid catabolizing enzyme, which should only be synthesized when its substrate is well in excess of the level required for tRNA charging and protein synthesis.
tna operon regulation involves p-dependent transcription termination. All four rho alleles we tested rendered tna expression partially constitutive. Tryptophanase gene expression in the rho-15 strain was striking, with an uninduced enzyme level roughly one-half that of the induced value ( Table 2 ). The only known function of p protein is as a factor required for transcription termination at certain termination sites (52, 58) . These results suggest that in wild-type cells, p-dependent transcription termination prevents tna operon expression under noninducing conditions.
Further support for this conclusion comes from our analysis of transcription termination in the tna leader region (V. Stewart, R. Landick, and C. Yanofsky, submitted for publication). p factor promoted efficient transcription termination within the leader region in an in vitro transcription system. We have also detected mRNA species in vivo which appear to correspond to the in vitro-terminated tna leader transcripts.
Indeed, the nucleotide sequence of the tna leader region has many characteristic features of p-dependent transcription termination sites (38, 41) . It encodes a long (over 200 base pairs) stretch of untranslated RNA, and it contains relatively few G residues (Fig. 2) .
Induction does not act at the tna promoter. The presumptive tna promoter has been identified by in vitro transcription experiments (18) . Expression of the tnaC'-lacZ+ gene fusion was indifferent to tryptophan, but it was decreased by VOL. 164, 1985 on October 28, 2017 by guest http://jb.asm.org/ Downloaded from glucose (Table 3 ). This indicates that the tna promoter is not regulated by tryptophan but that it is sensitive to catabolite repression, presumably mediated through cAMP-CRP (18) .
Induction involves suppression of transcription termination in the tna leader region. mRNA from the tnaC'-lacZ+ gene fusion was synthesized at a high constitutive level, while mRNA synthesis from the tnaA'-lacZ+ gene fusion was induced by tryptophan (Table 3) . These results suggest that induction acts to relieve transcription termination in the region between tnaC and tnaA. The tnaC'-lacZ+ gene fusion deletes the distal, nontranslated portion of the leader region, which contains the sites for p-dependent transcription termination ( Fig. 1; see above) .
Most constitutive alterations define a boxA-like sequence. A sequence termed boxA, near the bacteriophage X early rightward terminator (X tR1), is thought to provide a recognition site for a transcription control factor (23, 24, 48, 49) . The boxAS allele changes this sequence from 5'-CGCTCTTA-3' to 5'-CTCTCTTA-3' and significantly reduces N gene product-mediated antitermination at X tRl (49) . Most of the tnaC alleles define a sequence, 5'-CGCCCTTGA-3', that is similar to boxA (Fig. 3) . Thus, alterations in the boxA-like sequence in the tna leader region may impair the action of a transcription factor and thus reduce the efficiency of transcription termination under noninducing conditions.
The tnaC and boxAS alterations have opposite phenotypes; the former apparently reduced transcription termination, while the latter reduces transcription readthrough. One reason for this difference may involve the position of the sequence relative to a translated region. The boxA sequence near A tRl is located eight base pairs distal to the translation termination codon of the cro gene. Transcription readthrough at X tRl still occurs when cro translation is terminated early or abolished. However, readthrough is greatly reduced when cro translation is extended by as little as four base pairs (48, 49, 60) . In contrast, the boxA-like sequence in the tna leader actually overlaps the tnaC coding region (Fig. 3) .
The nusAl allele reduces antitermination in bacteriophage X lytic gene expression (reviewed in references 23 and 24), but it had little or no effect on tna expression (Table 2) . Friedman and co-workers have proposed that boxA provides a recognition site for the nusA protein, which is required for proper antitermination in bacteriophage X lytic gene expression (23, 24, 48, 49) . Our experiments did not address the hypothesis that the boxA-like sequence in the tna leader region serves as a recognition site for the nusA protein.
tna operon regulation may involve antitermination control. In view of these results, we propose a hypothesis for antitermination control of tna operon expression. This hypothesis closely parallels that for bacteriophage A lytic gene expression (reviewed in reference 23). In our model, transcription initiation at the tna promoter occurs efficiently, regulated only by cAMP-CRP-mediated transcription activation. In the absence of tryptophan, p-dependent transcription termination occurs in the tna leader region. We hypothesize that E. coli produces a tryptophan-responsive antitermination protein analogous to the N or Q proteins of X. With inducing levels of tryptophan, this hypothetical protein would act to reduce transcription termination in the leader region, thus allowing RNA polymerase to continue into the major structural genes of the tna operon.
We have not yet examined the role of the presumed tnaC peptide in tna operon regulation. The strictly cis-acting nature of tnaC mutants suggests that the peptide is not a diffusible regulatory element (see below). Further, the efficient induction by 5MT indicates that tnaC translation does not play a role analogous to that of the trp leader peptide (63) (see above). A simple working hypothesis is that tnaC translation serves to couple translation termination with p-dependent transcription termination. tna operon regulation does not involve repression control. A previous report described constitutive alterations that were thought to define a gene for a tna repressor protein (18) . We were unable to confirm that conclusion using those mutant strains (V. Stewart, unpublished observations).
A selection for constitutive mutants should yield two classes of mutants if the structural genes in question are subject to repression control. First, cis-acting constitutive lesions in such an operon should define the repressor-binding site (operator). In fact, the tnaC changes do not define a classical-type operator region; the sequence in this region does not make up part of a dyad symmetry, and it is located over 90 base pairs away from the promoter. Second, null (i.e., chain terminating or insertion) constitutive alterations would define the structural gene for the aporepressor and would act in trans. We have exhaustively searched for such lesions, and we believe that they do not exist (see Materials and Methods). Constitutive expression of the tnaC'-lacZ+ fusion (see above) also argues against repression control of tna operon expression.
We have no direct evidence for the hypothetical tna antitermination protein. If it is a positive regulator, then null alterations in its structural gene would confer an uninducible phenotype rather than a constitutive phenotype. We are developing methods to select for such mutants.
Most constitutive alterations do not act by affecting translation. The tnaC changes were strictly cis-dominant, indicating that the presumed tnaC peptide does not act as a diffusible regulatory element (see above). In addition, if tnaC255 acted by allowing readthrough of the tnaC peptide, then we believe that the high-efficiency, tryptophan-inserting suppressor Su7-UGA would have produced a constitutive phenotype in a wild-type strain (Fig. 3) . These findings suggest that most of the tnaC alterations did not act by changing the amino acid sequence of the tnaC peptide. We favor the alternate explanation: the lesions changed a boxAlike site within the tna leader region that is important for proper transcription termination (see above). We do not know if tnaC translation palys a role in regulating wild-type tna expression.
One allele, tnaC261, resulted from an insertion rather than a change of a single base pair. This lesion was outside of the boxA-like sequence defined by the other alleles (Fig. 3) , and it was also unusual in that tna was expressed at a high level irrespective of inducer (Table 4 ). The tnaC261 allele should have a frameshift effect and extend the tnaC coding region 25 codons past the normal termination codon to an ochre codon at position +171 (Fig. 2) . Current models postulate that p-mediated transcription termination requires a large segment (over 60 base pairs) of untranslated RNA (38, 41, 58) . We suggest that extended translation in the tnaC261 mutant simply masked RNA regions required for p binding or action.
Possible role for the tna leader in mediating catabolite repression. tna expression is subject to an unusually severe and complex catabolite repression (10, 11, and references therein). Ullmann and colleagues (30) have proposed a role for p in mediating catabolite repression of some genes. Several rho alleles had no detectable effect on glucosemediated catabolite repression of tna expression (30; this work). We also failed to observe relief of glycerol-mediated catabolite repression in the rho mutants (data not shown). However, glucose depressed mRNA expression from the tnaC'-lacZ+ fusion only about 15-fold, while it depressed expression from the tnaA'-lacZ+ fusion well over 100-fold (Table 3) . This suggests that a catabolite repression-sensitive regulatory site may exist in the leader region, in addition to the cAMP-CRP-sensitive site at the promoter.
Pastan and Perlman (50) had initially suggested that cAMP affects tryptophanase expression at a posttranscriptional step, but this conclusion has not been pursued (e.g., see reference 16). Our results suggest that both induction and glucose-mediated catabolite repression regulate the levels of tnaA mRNA production.
Other examples of antitermination control. Attenuation control of amino acid biosynthetic operons involves regulated transcription termination as a mechanism for controlling gene expression (63) . Attenuation is cis-acting in that no operon-specific diffusible factors are required for regulation. Transcription antitermination control of gene expression in lambdoid bacteriophages requires trans-acting regulatory proteins (23, 24, 29, 52) . However, few examples of antitermination have been thoroughly documented in E. coli.
A bacterial antitermination factor may be involved in rrn operon expression (1) . In addition, the bacterial genes sfrA and sfrB may mediate antitermination control of the F factor tra operon expression (5, 25) . If tna operon expression is subject to antitermination control, it represents the first example of this type of regulation of a dispensable, catabolic operon. Perhaps this unusual mechanism of genetic regulation is more common than currently appreciated.
